CN Stock MarketDetailed Quotes
688068 Beijing Hotgen Biotech Co.,Ltd
- 56.20
- +1.61+2.95%
Market Closed Nov 29 15:00 CST
5.20BMarket Cap-76880P/E (TTM)
59.79High52.60Low103.29KlotVolume56.00Open54.59Pre Close579.60MTurnover11.17%Turnover Ratio189.86P/E (Static)92.47MShares59.7952wk High1.59P/B5.20BFloat Cap22.9452wk Low65.51Limit Up92.47MShs Float161.30Historical High43.67Limit Down13.17%Amplitude18.59Historical Low0.20Dividend TTM56.12Avg Price47.47KlotAsk0.36%Div YieldTTM100Lot Size46.65KlotBid
Beijing Hotgen Biotech Co.,Ltd Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -5.10%386.16M | -18.96%248.81M | -42.78%116.12M | -84.78%541.25M | -86.48%406.92M | -84.99%307.01M | -85.13%202.94M | -33.76%3.56B | -20.72%3.01B | -43.17%2.05B |
| Operating revenue | -5.10%386.16M | -18.96%248.81M | -42.78%116.12M | -84.78%541.25M | -86.48%406.92M | -84.99%307.01M | -85.13%202.94M | -33.76%3.56B | -20.72%3.01B | -43.17%2.05B |
| Total operating cost | 10.78%444.86M | 12.20%295.46M | -17.76%123.89M | -74.35%589.24M | -77.24%401.56M | -76.36%263.34M | -76.63%150.64M | -15.45%2.3B | -4.20%1.76B | -31.26%1.11B |
| Operating cost | 25.72%183.67M | 19.70%124.46M | -22.21%47.57M | -85.85%232.99M | -89.00%146.09M | -88.20%103.98M | -87.96%61.15M | -24.22%1.65B | -9.29%1.33B | -33.25%881.32M |
| Operating tax surcharges | 21.35%4.12M | 27.96%3.01M | -11.88%877.3K | -53.21%4.69M | -48.21%3.39M | -54.23%2.36M | -25.76%995.57K | 96.29%10.02M | 214.92%6.55M | 233.58%5.15M |
| Operating expense | -1.31%129.08M | 17.54%90.9M | 9.75%38.57M | -36.35%171.15M | -26.69%130.8M | -19.75%77.34M | -48.54%35.15M | 15.02%268.92M | -2.59%178.43M | -33.34%96.38M |
| Administration expense | 33.38%70.85M | 26.15%42.3M | -19.56%22.01M | -57.27%91.73M | -60.92%53.12M | -43.95%33.53M | -4.65%27.36M | 25.93%214.66M | 19.04%135.93M | -35.62%59.81M |
| Financial expense | 35.31%-20.07M | 32.36%-14.87M | 0.89%-7.8M | -27.74%-42.78M | -38.86%-31.02M | -109.01%-21.98M | -1.01%-7.87M | -1,057.05%-33.49M | -462.12%-22.34M | -1,837.40%-10.52M |
| -Interest expense (Financial expense) | ---- | 6.46%173.09K | ---- | -56.49%1.01M | ---- | --162.59K | ---- | 82.14%2.32M | ---- | ---- |
| -Interest Income (Financial expense) | -51.60%-20.01M | 21.76%-15.15M | 14.58%-7.97M | -27.21%-39.59M | 41.80%-13.2M | -54.96%-19.37M | -117.37%-9.34M | -149.00%-31.12M | -155.29%-22.67M | -100.80%-12.5M |
| Research and development | -22.15%77.2M | -27.12%49.65M | -33.07%22.67M | -31.23%131.45M | -28.28%99.17M | -16.71%68.12M | -26.36%33.86M | 44.89%191.14M | 67.10%138.28M | 35.40%81.79M |
| Credit Impairment Loss | -117.13%-2.12M | -646.15%-4.04M | ---- | 219.05%12.1M | 1,071.15%12.39M | 2,169.71%739.55K | 100.05%114 | -232.60%-10.16M | 43.89%-1.28M | 97.28%-35.73K |
| Asset Impairment Loss | -101.82%-99.63K | -1,620.60%-545.96K | ---- | 93.63%-11.61M | -81.51%5.47M | -99.90%35.9K | 95.86%7.91M | -98.97%-182.22M | 112.15%29.6M | 112.86%34.27M |
| Other net revenue | ||||||||||
| Fair value change income | 218.94%19.7M | 53.98%-2.87M | 267.34%14.86M | -168.57%-5.15M | -193.02%-16.56M | -148.86%-6.23M | 0.22%4.05M | 140.64%7.52M | 266.86%17.81M | 333.38%12.75M |
| Invest income | 14.61%-9.4M | 615.03%2.9M | -510.20%-5.18M | -605.07%-17.16M | -7,241.28%-11.01M | 175.21%405.75K | -77.54%1.26M | -84.39%3.4M | -101.32%-149.98K | -115.11%-539.46K |
| -Including: Investment income associates | -160.24%-37.87M | -328.42%-25.14M | ---- | -129.60%-29.91M | ---14.55M | ---5.87M | ---- | -2,132.29%-13.03M | ---- | ---- |
| Asset deal income | 1,876.20%1.16M | 534.71%284.63K | 2,775.90%1.75M | -89.84%-642.72K | 80.66%-65.48K | 80.55%-65.48K | 68.66%-65.48K | 97.62%-338.56K | -301.76%-338.56K | -27,695.64%-336.67K |
| Other revenue | -77.75%11.17M | -81.18%8.85M | -43.94%1.78M | 543.04%87.67M | 709.60%50.2M | 4,788.12%47.03M | 311.98%3.17M | -17.15%13.63M | -56.96%6.2M | -89.80%962.05K |
| Operating profit | -183.65%-38.29M | -149.15%-42.06M | -92.06%5.45M | -98.42%17.21M | -96.47%45.78M | -91.26%85.58M | -90.65%68.62M | -57.79%1.09B | -25.41%1.3B | -43.34%978.83M |
| Add:Non operating Income | -19.04%1.65M | -90.95%171.74K | -88.95%78.68K | 54.55%2.6M | 50.44%2.03M | 103.72%1.9M | 202.52%711.83K | 165.14%1.68M | 192.64%1.35M | 150,877.61%932K |
| Less:Non operating expense | -54.67%1.21M | -15.16%1.18M | 491.41%420.72K | -63.60%6.3M | -59.37%2.66M | -78.27%1.39M | -97.72%71.14K | 434.20%17.31M | 327.07%6.55M | 1,244.72%6.4M |
| Total profit | -183.84%-37.85M | -150.03%-43.07M | -92.63%5.1M | -98.74%13.5M | -96.50%45.15M | -91.16%86.09M | -90.52%69.26M | -58.35%1.08B | -25.67%1.29B | -43.64%973.36M |
| Less:Income tax cost | 370.41%4.83M | -73.27%2.59M | -88.05%1.57M | -101.03%-1.55M | -100.96%-1.79M | -93.32%9.69M | -88.60%13.16M | -60.44%150.1M | -26.25%185.95M | -45.42%145.19M |
| Add:Adjusted items effecting net profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 |
| Net profit | -190.94%-42.68M | -159.77%-45.66M | -93.71%3.53M | -98.37%15.05M | -95.75%46.94M | -90.78%76.4M | -90.88%56.1M | -57.99%925.12M | -25.57%1.11B | -43.31%828.17M |
| Net profit from continuing operation | -190.94%-42.68M | -159.77%-45.66M | -93.71%3.53M | ---- | --46.94M | -90.78%76.4M | -90.88%56.1M | ---- | ---- | -43.31%828.17M |
| Less:Minority Profit | 72.56%-2.04M | 73.79%-2.19M | 45.34%-1.52M | 37.16%-12.33M | -293.29%-7.45M | -162.54%-8.37M | -129.52%-2.79M | -218.10%-19.62M | -55.79%3.85M | 60.72%13.39M |
| Net profit of parent company owners | -174.73%-40.64M | -151.28%-43.47M | -91.42%5.05M | -97.10%27.38M | -95.06%54.38M | -89.60%84.77M | -90.28%58.88M | -56.78%944.74M | -25.39%1.1B | -43.91%814.78M |
| Earning per share | ||||||||||
| Basic earning per share | -172.13%-0.44 | -149.47%-0.47 | -90.91%0.06 | -97.00%0.31 | -94.90%0.61 | -89.27%0.95 | -89.97%0.66 | -56.51%10.33 | -25.37%11.97 | -43.92%8.85 |
| Diluted earning per share | -172.13%-0.44 | -149.47%-0.47 | -90.91%0.06 | -96.98%0.31 | -94.90%0.61 | -89.27%0.95 | -89.97%0.66 | -56.72%10.28 | -25.37%11.97 | -43.92%8.85 |
| Other composite income | 551.75%439.02K | 36.50%-221.52K | -132.10%-86.48K | -121.93%-97.18K | -3,937.22%-348.88K | 298.08%269.44K | 394.95%443.14K | 93.65%-8.64K | ||
| Other composite income of parent company owners | 525.45%439.43K | 37.29%-221.11K | ---- | -130.98%-83.19K | -123.32%-103.29K | -4,714.53%-352.61K | ---- | 299.31%268.5K | 394.79%442.89K | 94.57%-7.32K |
| Other composite income of minority owners | -106.73%-410.61 | -111.01%-410.6 | ---- | -448.99%-3.29K | 2,379.60%6.1K | 383.03%3.73K | ---- | 171.60%943.43 | --246.18 | 3.22%-1.32K |
| Total composite income | -190.19%-42.24M | -160.34%-45.88M | -93.71%3.53M | -98.38%14.97M | -95.76%46.84M | -90.82%76.05M | -90.88%56.1M | -57.98%925.39M | -25.53%1.11B | -43.31%828.16M |
| Total composite income of parent company owners | -174.06%-40.2M | -151.75%-43.69M | -91.42%5.05M | -97.11%27.3M | -95.07%54.28M | -89.64%84.42M | -90.28%58.88M | -56.76%945.01M | -25.35%1.1B | -43.90%814.77M |
| Total composite income of minority owners | 72.54%-2.04M | 73.77%-2.2M | 45.34%-1.52M | 37.14%-12.33M | -293.12%-7.44M | -162.52%-8.37M | -129.52%-2.79M | -218.10%-19.62M | -55.78%3.85M | 60.73%13.39M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data